MyMD Pharmaceuticals Inc (NAS:MYMD)
$ 1.9 0.09 (4.97%) Market Cap: 4.50 Mil Enterprise Value: 2.74 Mil PE Ratio: 0 PB Ratio: 0.42 GF Score: 37/100

MyMD Pharmaceuticals Inc at Dawson James Small Cap Growth Stock Conference (Virtual) Transcript

Oct 21, 2021 / 08:30PM GMT
Release Date Price: $269.7 (+5.52%)
Unidentified Analyst

Hi, everyone. Thanks for joining us. I have Dr. Adam Kaplin here from MyMD, super exciting biotech company. I love the technology. I'm an investor.

And without further ado, here's Dr. Kaplin.

Adam Kaplin
MyMD Pharmaceuticals, Inc. - Chief Scientific Officer

Great. Thanks very much. And for those of you who feel like you're watching time pass being at this, the good news is we have a treatment that we think is going to be anti-aging. And if you're anxious about getting out of here, the other thing is we've got a cannabinoid that's good for anxiety. So let me get right to it.

So of course the caveats that everybody shows.

So I'm going to be talking about our two drug candidates. First one is MYMD-1. It's an immuno-regulator. Supera-CBD is a super form of CBD, and I'll put my money or data where my mouth is and tell you about that. I'm the Chief Scientific Officer, but it takes a village and a team. Chris Chapman is the President. He has been at IQVIA for over 30 years. He has put many drugs -- helped with -- put many

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot